Bibliography

Found 1068 results

Journal Article

Gutierrez J, Menshawy K, Gonzalez M, Goldman J, Elkind MSV, Marshall R, Morgello S. Brain large artery inflammation associated with HIV and large artery remodeling. AIDS. 2016 ;30(3):415-23.

Gutierrez J, Menshawy K, Gonzalez M, Elkind MSV, Marshall RS, Dwork AJ, Morgello S. Brain large artery inflammation associated with human immunodeficiency virus and large artery remodeling. AIDS. 2016 ;30(3):415-423.

Shenoy A, Dwork A, Elkind MSV, Marshall R, Morgello S, Gutierrez J. Brain Large Artery Lymphocytic Inflammation and Human Immunodeficiency Virus-Related Brain Arterial Remodeling. J Virol. 2018 ;92(12).

Shapshak P, Stewart RV, Rodriguez de la Vega P, Dominguez B, Fujimura RK, Segal DM, Sun NC, Delgado S, Petito C. Brain macrophage surface marker expression with HIV-1 infection and drug abuse: a preliminary study. Journal of NeuroAIDS [Internet]. 2002 ;2(3):37-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16873198

Tang Y, Chaillon A, Gianella S, Wong LM, Li D, Simermeyer TL, Porrachia M, Ignacio C, Woodworth B, Zhong D, et al. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest. 2023 ;133(12).

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez RG, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458

Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, et al. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014 ;20(6):603-11.

Hunter MD, Shenoy A, Dwork A, Elkind MSV, Marshall R, Mohr JP, Morgello S, Gutierrez J. Brain vascular intima vulnerability among HIV-positive and negative individuals. AIDS. 2018 ;32(15):2209-2216.

Lamers SL, Fogel GB, Liu ES, Barbier AE, Rodriguez CW, Singer EJ, Nolan DJ, Rose R, McGrath MS. Brain-specific HIV Nef identified in multiple patients with neurological disease. J Neurovirol. 2018 ;24(1):1-15.

Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC. Calcification of the internal elastic lamina of coronary arteries. Modern Pathology [Internet]. 2008 ;21:1019-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18536656

Colacurcio D, Yeager A, Kolson DL, Jordan-Sciutto KL, Akay C. Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage. Molecular and Cellular Neurosciences [Internet]. 2013 ;57:54-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24128662

Gianella S, Taylor J, Brown TR, Kaytes A, Achim CL, Moore DJ, Little SJ, Ellis RJ, Smith DM. Can research at the end of life be a useful tool to advance HIV cure?. AIDS. 2017 ;31(1):1-4.

Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh H-S, Lee SC. Cannabinoid Receptor Expression in HIV Encephalitis and HIV-associated Neuropathologic Comorbidities. Neuropathology and Applied Neurobiology [Internet]. 2011 ;37(5):464-483. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21450051

Watson CWei-Ming, Paolillo EW, Morgan EE, Umlauf A, Sundermann EE, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Grant I. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.

Twu C, Liu NQ, Popik W, Bukrinsky M, Sayre JW, Roberts J, Rania S, Bramhandam V, Roos KP, MacLellan WR, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2002 ;99(22):14386-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12379743

Kim JY, Singer EJ, Bonelli L, Klausner JD. A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease. J Int Assoc Provid AIDS Care. 2014 ;13(3):196-9.

Ohene-Nyako M, Nass SR, Richard HT, Lukande R, Nicol MR, McRae M, Knapp PE, Hauser KF. Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia. ASN Neuro. 2023 ;15:17590914231158218.

Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D'Emilia DM, Friedlander RM, Yuan J, Masliah E, Lipton SA. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience [Internet]. 2002 ;22(10):4015-24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12019321

Kearns AC, Liu F, Dai S, Robinson JA, Kiernan E, Cheru LTesfaye, Peng X, Gordon J, Morgello S, Abuova A, et al. Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort. Arterioscler Thromb Vasc Biol. 2019 ;39(9):1762-1775.

Xu J, Umlauf A, Letendre S, Franklin D, Bush WS, Atkinson JH, Keltner J, Ellis RJ. Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy. AIDS. 2019 ;33(10):1575-1582.

Fields J, Gardner-Mercer J, Borgmann K, Clark I, Ghorpade A. CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. Journal of Neurochemistry [Internet]. 2011 ;118(1):93-104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21281310

Levine AJ, Singer EJ, Sinsheimer JS, Hinkin CH, Papp J, Dandekar S, Giovanelli A, Shapshak P. CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehavioral HIV Medicine [Internet]. 2009 ;1:1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725607

Brown A, Sacktor N, Marder K, Cohen BA, Schifitto G, Skolasky RL, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder. Journal of Current Biomarker Findings [Internet]. 2012 ;2012(2):1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23814703

Williams DW, Byrd D, Rubin LH, Anastos K, Morgello S, Berman JW. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm [Internet]. 2014 ;1(3):e36. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25340088

Veenstra M, Byrd D, Inglese M, Buyukturkoglu K, Williams DW, Fleysher L, Li M, Gama L, Leon-Rivera R, Calderon TM, et al. CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. Journal of Neuroimmune Pharmacology [Internet]. 2018 ;14. Available from: https://doi.org/10.1007/s11481-018-9792-7

Pages